#Viral
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump...
Posted on: May 19, 2009 user submitted | Views: | Comment
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation.
Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has been approved by the U.S. Food and Drug Administration (FDA) as the first over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent heartburn since 2003. Prevacid 24HR is expected to be available over-the-counter in 2009.
To view Multimedia News Release, go to http://www.prnewswire.com/mnr/prevacid/38457/
